<DOC>
	<DOCNO>NCT02496650</DOCNO>
	<brief_summary>The objective randomized control study evaluate whether DEX addition benzodiazepine therapy effective safe AWS patient intensive care unit ( ICU ) . Eligible participant randomly assign intervention ( D ) control ( C ) group . In group D DEX infusion start dos 0,2-1,4 μg/kg/hr titrate achieve target sedation level ; symptom-triggered BZD administration ( diazepam 10mg bolus ) use wherever DEX infusion enough . In group K BZD bolus ( diazepam 10mg ) use achieve target sedation level control AWS symptom ( symptom-triggered administration ) . The primary efficacy outcomes 24-hour diazepam consumption cumulative diazepam dose require course ICU stay , secondary outcome length ICU stay , sedation communication quality , haloperidol consumption .</brief_summary>
	<brief_title>Dexmedetomidine Addition Benzodiazepines Patients With Alcohol Withdrawal State ICU</brief_title>
	<detailed_description>Ethical issue This study approve Bogomolets National Medical University ethic committee write informed concern obtain patient , patient 's family legal representative . Study design This randomize , single-center , control study conduct adult ICU private hospital `` Boris '' Kiyv ( Ukraine ) . The inclusion criterion : age 18 old , sign informed concern , within 2 hour ICU admission , diagnose alcohol withdrawal syndrome alcohol withdrawal delirium DSM IV criterion ( ) . The exclusion criterion age young 18 old 75 , history use withdrawal state psychoactive substance , general anesthesia last 24 hour know sedative use , severe neurologic disorder ( traumatic brain injury , acute stroke , severe dementia ) , pregnancy lactation , severe comorbidities ( severe heart failure , acute myocardial infarction , heart rate &lt; 50/min , glomerular filtration rate &lt; 30 ml/min , liver failure Child-Pugh class C ) , know allergy study medication . After primary patient assessment target sedation level set individually study treatment begin . Eligible participant randomly assign 1:1 ratio intervention ( group D ) control group use random assignment block four . In group D DEX infusion start dos 0,2-1,4 μg/kg/hr titrate achieve target sedation level ; symptom-triggered BZD administration ( diazepam 10mg bolus ) use wherever DEX infusion enough . In group K BZD bolus ( diazepam 10mg ) use achieve target sedation level control AWS symptom ( symptom-triggered administration ) . Antipsychotics ( haloperidol 5mg bolus ) use rescue medication group severe agitation hallucination . Study outcomes statistical analysis The primary efficacy outcomes 24-hour diazepam consumption study begin cumulative diazepam dose required course ICU stay . The secondary efficacy outcome include : - length ICU stay intubation rate ; - sedation quality : time target sedation ( proportion time target sedation range ( case RASS score 0 -2 ) total sedation time ) ; time insufficient sedation ( duration ineffective sedation ( case RASS score ≥+2 ) total sedation time ) ; time oversedation ( duration excessive sedation ( case RASS ≤-3 ) total sedation time ) ; number rescue sedation boluses sedation stop 24 hour ; - communication quality ( 0 10 , 0 - uncommunicative , 10 - patient communicates well ) ability asses pain Visual Analogue Scale ( VAS ) ; - haloperidol requirement cumulative dose ICU stay . Safety estimate monitoring vital sigh , ECG , laboratory test ( paO2 , SaO2 , blood sugar ) , adverse event . Adverse event evaluate systolic blood pressure low 90 mm Hg high 160 mm Hg heart rate lower 50/min high 110/min ; desaturation estimate SpO2 ( SaO2 ) low 90 % ; hypoglycemia define serum glucose low 4 mmol/L hyperglycemia high 10 mmol/L . Intervention bradycardia , tachycardia , hypertension hypotension titration interruption study agent drug therapy . Sedation assess use Richmond Agitation Sedation Scale ( RASS ) AWS symptom severity - Clinical Institute Withdrawal Assessment Alcohol Scale , Revised ( CIWA-Ar ) . RASS monitor every 2-6 hour prior rescue therapy , CIWA-Ar assess daily basis sedation stop . Randomization sequence generate use computer algorithm [ www.random.org ] . Both randomization data analysis conduct independent blind member research team . A statistical analysis perform use Statistics 6.0 R software . Categorical data present proportion ; continuous data - median ( InterQuartile Range , IQR 25-75 % ) . Chi-square test demonstrates variable study discrete . To assess significance two-tailed Mann-Whitney U test Fisher exact test use . A P-value le 0.05 define significant .</detailed_description>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>age 18 old , sign informed concern , within 2 hour ICU admission , diagnose alcohol withdrawal syndrome alcohol withdrawal delirium DSM IV criterion young 18 old 75 , history use withdrawal state psychoactive substance , general anesthesia last 24 hour know sedative use , severe neurologic disorder ( traumatic brain injury , acute stroke , severe dementia ) , pregnancy lactation , severe comorbidities ( severe heart failure , acute myocardial infarction , heart rate &lt; 50/min , glomerular filtration rate &lt; 30 ml/min , liver failure ChildPugh class C ) , know allergy study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>alcohol withdrawal state</keyword>
	<keyword>dexmedetomidine</keyword>
	<keyword>benzodiasepines</keyword>
	<keyword>intensive care</keyword>
</DOC>